Table 2

Changes in Screening Attitudes Toward Cancer Screening

MeasureAfter Printed (Control) Intervention Mean Change (P Value)aAfter Video Intervention Mean Change (P Value)aVideo vs Print Difference Mean Change (P Value)a
PSA screening
 Want PSA (yes = 2, unsure = 1, no = 0)0.0 (>.99)−0.93 (<.001)−0.88 (<.001)
 PSA right for meb0.0 (>.99)−1.6 (<.001)−1.6 (<.001)
 PSA harm-benefit balanceb−0.53 (.01)−1.9 (<.001)−1.3 (.007)
 Intend to discuss PSA with physicianb0.12 (.38)−0.44 (.03)−0.58 (.003)
Mammography screening
 Want mammography (yes = 2, unsure = 1, no = 0)−0.06 (.75)−0.50 (<.001)−0.44 (.01)
 Mammography right for meb0.06 (.82)−0.77 (<.001)−0.83 (.002)
 Mammography harm-benefit balanceb−0.14 (.38)−0.65 (<.001)−0.50 (.046)
 Intend to discuss mammography with physicianb0.0 (>.99)−0.29 (.07)−0.29 (.17)
  • PSA = prostate-specific antigen.

  • Note: Interventions were presented to participants randomly.

  • a Wilcoxon signed rank tests used to assess significance.

  • b Score based on 5-point Likert scale, where 1= definitely yes, to 5 = definitely no.